Autism spectrum disorder. autism spectrum disorder
Conditions
Interventions
Intervention 1: Intervention group: people in this group are already receiving occupational therapy and taking risperidone, and at the same time, they are prescribed atentaline drug for two months. In
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 7 Years
Inclusion criteria
Inclusion criteria: Age 3 to 7 years of patients with autism spectrum disorder_informed consent of the patient's parents or legal guardian to participate in the study_have a history of using risperidone for at least 1 month_ Have a history of occupational therapy for at least 6 months_Not using drugs that interfere with attentalin _no previous use of attentaline syrup_Not having gastrointestinal diseases such as peptic ulcers_No food or drug sensitivities_No skin sensitivity to light_Do not use medications that interfere with attentaline (MAOIs, midazolam, or CNS suppressants).
Exclusion criteria
Exclusion criteria: Reluctance to participate in the study, age outside this range, reluctance to take medication, use of drugs that interfere with attentaline_previous use of etentaline syrup, gastrointestinal diseases such as peptic ulcers, food or drug allergies, skin sensitivity to light, use of drugs that interfere with attentaline (MAOIs, midazolam, or CNS suppressive drugs)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GARS3 test and CBCL test and the questionnaire of drug side effects of atentalin scores will be evaluated. Timepoint: Completion of GARS 3 and CBCL questionnaire at the beginning of the study, two weeks later and two months after the start of treatment. Method of measurement: GARS3- CBCL- Attentalin side effect. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAnita alaghemand
Arak University of Medical Sciences
Outcome results
None listed